Genoplan
Startup specializing in DNA testing, analyzes user’s saliva to conduct genetic analysis and give life style advice tailored for each user, including diet, health food, work-out, and cosmetics.
Launch date
Employees
Market cap
-
Enterprise valuation
$37—55m (Dealroom.co estimates Dec 2020.)
Company register number 1208812093
Seoul South Korea (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $500k | Seed | |
$4.5m | Series A | ||
| N/A | $4.2m | Early VC | |
| N/A | $14.0m | Series B | |
| N/A | $9.2m | Series C | |
| Total Funding | $32.4m | ||
Related Content
Recent News about Genoplan
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.